Literature DB >> 15507067

Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease.

Mary M McDermott1, Jack M Guralnik, Philip Greenland, David Green, Kiang Liu, Paul M Ridker, Cheeling Chan, Michael H Criqui, Luigi Ferrucci, Lloyd M Taylor, William H Pearce, Joseph R Schneider, Sarah I Oskin.   

Abstract

OBJECTIVES: To determine whether higher circulating levels of thrombotic and inflammatory markers are associated with greater disability.
DESIGN: Cross-sectional.
SETTING: Academic medical center. PARTICIPANTS: A total of 346 men and women with peripheral arterial disease (PAD) and 203 without PAD. MEASUREMENTS: Disability measures were the Walking Impairment Questionnaire (WIQ) distance, speed, and stair-climbing scores and the 36-item Short-Form (SF-36) physical functioning score. The SF-36 and WIQ are scored on a 0 to 100 scale (100=best).
RESULTS: In persons with PAD, higher D-dimer levels were associated with lower WIQ speed scores (P<.001), lower stair-climbing scores (P<.04), and poorer SF-36 physical functioning scores (P<.01), adjusting for known and potential confounders. In participants without PAD, higher D-dimer levels were associated with lower WIQ distance scores (P<.03), lower speed scores (P<.05), and poorer SF-36 physical functioning scores (P<.02). Higher high-sensitivity C-reactive protein (hsCRP) levels were associated with lower WIQ distance (P<.02) and speed scores (P<.001) in persons without PAD. Most of these associations were attenuated after additional adjustment for objectively measured functional limitations.
CONCLUSION: Higher circulating D-dimer and hsCRP levels are associated with greater disability in walking and physical functioning in individuals with and without PAD. Physiological changes that result in walking disability may mediate these associations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507067     DOI: 10.1111/j.1532-5415.2004.52514.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  15 in total

Review 1.  Antithrombotic treatment for peripheral arterial disease.

Authors:  Daniel G Hackam; John W Eikelboom
Journal:  Heart       Date:  2006-10-11       Impact factor: 5.994

2.  Inflammation, coagulation and risk of locomotor disability in elderly women: findings from the British Women's Heart and Health Study.

Authors:  Eveline Nüesch; Caroline E Dale; Antoinette Amuzu; Hannah Kuper; Ann Bowling; George B Ploubidis; Gordon Lowe; Ann Rumley; Shah Ebrahim; Juan P Casas
Journal:  Eur J Epidemiol       Date:  2012-06-19       Impact factor: 8.082

3.  Cu to Zn ratio, physical function, disability, and mortality risk in older elderly (ilSIRENTE study).

Authors:  Eugenio Mocchegiani; Marco Malavolta; Fabrizia Lattanzio; Francesco Piacenza; Andrea Basso; Angela Marie Abbatecola; Andrea Russo; Silvia Giovannini; Ettore Capoluongo; Silvia Bustacchini; Enrico Eugenio Guffanti; Roberto Bernabei; Francesco Landi
Journal:  Age (Dordr)       Date:  2011-05-05

4.  Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery.

Authors:  Christopher D Owens; Paul M Ridker; Michael Belkin; Allen D Hamdan; Frank Pomposelli; Frank Logerfo; Mark A Creager; Michael S Conte
Journal:  J Vasc Surg       Date:  2006-11-21       Impact factor: 4.268

Review 5.  Evidence-based management of peripheral vascular disease.

Authors:  Nicolas W Shammas; Eric J Dippel
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

6.  Cognitive functioning is related to physical functioning in a longitudinal study of women at midlife.

Authors:  Kathleen Ford; Maryfran Sowers; Teresa E Seeman; Gail A Greendale; Barbara Sternfeld; Susan A Everson-Rose
Journal:  Gerontology       Date:  2009-10-10       Impact factor: 5.140

7.  Physical functioning related to C-reactive protein and fibrinogen levels in mid-life women.

Authors:  Kristin Tomey; MaryFran Sowers; Huiyong Zheng; Elizabeth A Jackson
Journal:  Exp Gerontol       Date:  2009-10-09       Impact factor: 4.032

Review 8.  Novel markers of peripheral arterial disease.

Authors:  Farhan J Khawaja; Iftikhar J Kullo
Journal:  Vasc Med       Date:  2009-11       Impact factor: 3.239

Review 9.  Percutaneous treatment of peripheral vascular disease: the role of diabetes and inflammation.

Authors:  Louis L Nguyen
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

10.  Association between concurrent and remote blood pressure and disability in older adults.

Authors:  Ihab Hajjar; Daniel T Lackland; L Adrienne Cupples; Lewis A Lipsitz
Journal:  Hypertension       Date:  2007-11-19       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.